Close

Form SC 13D/A Forma Therapeutics Holdi Filed by: RA CAPITAL MANAGEMENT, L.P. Oct 14, 2022 04:05PM
Form SC 13D/A Forma Therapeutics Holdi Filed by: RA CAPITAL MANAGEMENT, L.P. Sep 2, 2022 04:30PM
Novo Nordisk to acquire Forma Therapeutics and expand presence in sickle cell disease and rare blood disorders Sep 1, 2022 08:01AM
Forma Therapeutics (FMTX) Acquired by Novo Nordisk for $20/sh or $1.1B Sep 1, 2022 08:01AM
Novo Nordisk to acquire Forma Therapeutics and expand presence in sickle cell disease and rare blood disorders Sep 1, 2022 08:00AM


Oct 28, 2021 04:32PM Form SC 13D/A Forma Therapeutics Holdi Filed by: RA CAPITAL MANAGEMENT, L.P.
Jun 25, 2020 05:02PM Form SC 13D Forma Therapeutics Holdi Filed by: RA CAPITAL MANAGEMENT, L.P.